Metformin study for prostate cancer patients with weight or sugar issues
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This early-phase study tests whether metformin can help prostate cancer patients who have higher body weight and/or early blood sugar problems. You would be screened for eligibility using your medical record, and the study looks mainly at your current health factors and medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a man age 18 or older and sign the consent form in your patient portal or in Epic
- Have a prostate cancer diagnosis
- Have a UCHealth care relationship with a participating provider
- In the last year, have either early blood sugar elevation (A1c 5.7% to 6.4%) and/or higher body weight (BMI 25 or more)
- Not currently take metformin or other diabetes medicines that list on the study as excluded (insulin, many pills, and diabetes injections)
- Have no reason metformin would be unsafe for you (such as kidney function too low, certain liver problems, or a known metformin allergy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial studies whether metformin, added to standard hormone-blocking treatment, can improve outcomes for men with newly diagnosed metastatic hormone-sensitive prostate cancer. It’s meant to test benefits of targeting metabolism in addition to prostate cancer hormone therapy.
This study tests if metformin, a common diabetes medicine, can help reduce insulin resistance in women who finished chemotherapy for early-stage breast cancer. It aims to improve long-term health and prevent future problems.
This trial tests if adding metformin, a common diabetes drug, to standard chemotherapy or immunotherapy can help treat advanced solid tumors. It may be an option for people who are already eligible for chemo or immunotherapy.
This trial studies whether a diabetes medicine called metformin can help prevent or control non-muscle-invasive bladder cancer inside the bladder. You would take it by mouth, and the study checks safety and whether it works.
This trial tests whether a combination of two diabetes medicines, henagliflozin and metformin, can improve body composition (fat and muscle) in older adults new to diabetes treatment. It may help you better manage blood sugar and body weight.
This trial tests two medications (metformin and a turmeric compound) as a maintenance therapy for men with prostate cancer whose PSA is rising slowly after prior treatment. The goal is to see if these drugs can keep the cancer from growing while you take a break from standard hormone therapy.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.